Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 30 articles: HTML format

Single Articles

September 2025
1. WANG J, Wu Z, Verhoeven RHA, Goense L, et al
   A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
   Ann Surg. 2025 Sep 23. doi: 10.1097/SLA.0000000000006869.
   PubMed     Abstract available
   
   
   August 2025
2. OKUI J, Matsuda S, Nagashima K, Sato Y, et al
   Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
   Ann Surg. 2025 Aug 25. doi: 10.1097/SLA.0000000000006919.
   PubMed     Abstract available
   
   
   
3. ANTUNEZ AG, Sinco BR, Saucke MC, Bushaw KJ, et al
   Making Choices: A Multi-institutional, Longitudinal Cohort Study Assessing Changes in Treatment Outcome Valuation for Low-risk Thyroid Cancer.
   Ann Surg. 2025;282:275-282.
   PubMed     Abstract available
   
   
   July 2025
4. FEENSTRA ML, Kooij CD, Eshuis WJ, de Groot EM, et al
   Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter Trial.
   Ann Surg. 2025;282:29-36.
   PubMed     Abstract available
   
   
   June 2025
5. NAKAUCHI M, Walch HS, Nussenzweig S, Carr R, et al
   Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification.
   Ann Surg. 2025;281:989-996.
   PubMed     Abstract available
   
   
   March 2025
6. TAKEI S, Kotani D, Laliotis G, Sato K, et al
   Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.
   Ann Surg. 2025 Mar 21. doi: 10.1097/SLA.0000000000006699.
   PubMed     Abstract available
   
   
   
7. NA KJ, Kang CH, Kim YR, Kang MJ, et al
   Comparison of Clinical Outcomes and Postoperative Nutritional Status Between Early and Late Oral Feeding After Esophagectomy: An Open Labeled Randomized Controlled Trial.
   Ann Surg. 2025;281:388-394.
   PubMed     Abstract available
   
   
   November 2024
8. SIHAG S
   Real-world Application of Endoscopic Resection for Early-stage Esophageal Cancer: do we need to rethink the guidelines?
   Ann Surg. 2024 Nov 20. doi: 10.1097/SLA.0000000000006593.
   PubMed    
   
   
   
9. PUCCETTI F, Cinelli L, Barbieri LA, Socci D, et al
   The Near-Infrared Visualization and Preemptive Ligation of the Thoracic Duct Effectively Reduce the Chyle Leak Incidence After Minimally Invasive Esophagectomy.
   Ann Surg. 2024;280:780-787.
   PubMed     Abstract available
   
   
   
10. WIRSIK NM, Kooij CD, Dempster N, Crnovrsanin N, et al
    Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2024;280:799-807.
    PubMed     Abstract available
    
    
    October 2024
11. MARKAR SR, Sgromo B, Evans R, Griffiths EA, et al
    The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study.
    Ann Surg. 2024;280:650-658.
    PubMed     Abstract available
    
    
    September 2024
12. PUCHER PH, Rahman SA, Bhandari P, Blencowe N, et al
    Prevalence and Risk Factors for Malignant Nodal Involvement in Early esophago-gastric Adenocarcinoma: Results from the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy For Early Esophagogastric Cancers).
    Ann Surg. 2024 Sep 2. doi: 10.1097/SLA.0000000000006496.
    PubMed     Abstract available
    
    
    August 2024
13. DONLON NE, Moran B, Davern M, Davey MG, et al
    Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006487.
    PubMed     Abstract available
    
    
    
14. OVERTOOM HCG, Eyck BM, van der Wilk BJ, Noordman BJ, et al
    Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006488.
    PubMed     Abstract available
    
    
    
15. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of Preoperative Time Intervals for Neoadjuvant Chemoradiotherapy on Short-term Postoperative Outcomes of Esophageal Cancer Surgery: A Population-Based Study Using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) Data.
    Ann Surg. 2024 Aug 8. doi: 10.1097/SLA.0000000000006476.
    PubMed     Abstract available
    
    
    July 2024
16. DEBOEVER N, Correa AM, Feldman H, Eisenberg M, et al
    Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.
    Ann Surg. 2024;280:91-97.
    PubMed     Abstract available
    
    
    April 2024
17. HENCKENS SP, Schuring N, Elliott JA, Johar A, et al
    Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study.
    Ann Surg. 2024 Apr 5. doi: 10.1097/SLA.0000000000006280.
    PubMed     Abstract available
    
    
    March 2024
18. AIOLFI A, Bona D, Bonitta G, Bonavina L, et al
    Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis.
    Ann Surg. 2024;279:410-418.
    PubMed     Abstract available
    
    
    January 2024
19. PARK SY, Park B, Yun JK, Kim HR, et al
    Proposal of New ypStage Grouping System for Esophageal Squamous Cell Carcinoma Patients who Underwent Neoadjuvant Chemoradiotherapy followed by Surgery.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006204.
    PubMed     Abstract available
    
    
    December 2023
20. KARALIS JD, Ju MR, Yoon LY, Castro-Dubon EC, et al
    Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.
    Ann Surg. 2023;278:918-924.
    PubMed     Abstract available
    
    
    
21. OWEN RP, Chidambaram S, Griffiths EA, Sultan J, et al
    Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC study).
    Ann Surg. 2023;278:910-917.
    PubMed     Abstract available
    
    
    November 2023
22. WIRSIK NM, Schmidt T, Nienhuser H, Donlon NE, et al
    Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2023;278:683-691.
    PubMed     Abstract available
    
    
    
23. VEZIANT J, Boudis F, Lenne X, Bruandet A, et al
    Outcomes Associated With Esophageal Perforation Management: Results From a French Nationwide Population-based Cohort Study.
    Ann Surg. 2023;278:709-716.
    PubMed     Abstract available
    
    
    
24. ELLIOTT JA, Klevebro F, Mantziari S, Markar SR, et al
    Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Ann Surg. 2023;278:692-700.
    PubMed     Abstract available
    
    
    
25. HWANG H, Choi JY, Yu HW, Moon JH, et al
    Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
    Ann Surg. 2023;278:e1087-e1095.
    PubMed     Abstract available
    
    
    June 2023
26. 
    Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study: Erratum.
    Ann Surg. 2023;277:e1397.
    PubMed    
    
    
    May 2023
27. BOERNER T, Harrington C, Tan KS, Adusumilli PS, et al
    Waiting to Operate: The Risk of Salvage Esophagectomy.
    Ann Surg. 2023;277:781-788.
    PubMed     Abstract available
    
    
    
28. YAN L, Liu Y, Li W, Zhu Y, et al
    Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Ann Surg. 2023;277:846-853.
    PubMed     Abstract available
    
    
    
29. BAYLEY EM, Ivy ML, Shewale JB, Ge PS, et al
    High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
    Ann Surg. 2023;277:721-726.
    PubMed     Abstract available
    
    
    
30. 
    Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).
    Ann Surg. 2023;277:e1026-e1034.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.